Literature DB >> 18945879

Downregulation of CD40 ligand response in monocytes from sepsis patients.

Anna Sinistro1, Cristiana Almerighi, Chiara Ciaprini, Silvia Natoli, Emanuele Sussarello, Sara Di Fino, Francesca Calò-Carducci, Giovanni Rocchi, Alberto Bergamini.   

Abstract

It has been suggested that a defective adaptive immune response contributes to septic immunosuppression. Here, the response of monocytes to CD40 ligand (CD40L) for patients with sepsis due to infection with gram-negative organisms has been analyzed. Compared to cells from controls, monocytes from septic patients showed significantly reduced production of tumor necrosis factor alpha, interleukin-1beta (IL-1beta), and IL-12 and were unable to acquire high levels of CD80 and CD86 molecules. These alterations were observed at the onset of sepsis and persisted at day 7. However, the ability of monocytes to respond to CD40L stimulation was partially but significantly restored in cells from patients who recovered from sepsis. In addition, costimulation of autologous CD4+ T lymphocytes by CD40L-activated monocytes from septic patients failed to induce cell proliferation and gamma interferon production. Finally, the ability of CD40L to rescue monocytes from apoptosis was severely impaired. We conclude that downregulation of the CD40L response may be an appropriate model for the monocyte alteration observed during septic immunosuppression and may help in the development of novel therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18945879      PMCID: PMC2593171          DOI: 10.1128/CVI.00184-08

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  53 in total

Review 1.  Clinical aspects: from systemic inflammation to 'immunoparalysis'.

Authors:  H D Volk; P Reinke; W D Döcke
Journal:  Chem Immunol       Date:  2000

2.  Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans.

Authors:  R S Hotchkiss; K W Tinsley; P E Swanson; R E Schmieg; J J Hui; K C Chang; D F Osborne; B D Freeman; J P Cobb; T G Buchman; I E Karl
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

Review 3.  CD40 and dendritic cell function.

Authors:  Brendan O'Sullivan; Ranjeny Thomas
Journal:  Crit Rev Immunol       Date:  2003       Impact factor: 2.214

Review 4.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

5.  Improved innate immunity of endotoxin-tolerant mice increases resistance to Salmonella enterica serovar typhimurium infection despite attenuated cytokine response.

Authors:  M D Lehner; J Ittner; D S Bundschuh; N van Rooijen; A Wendel; T Hartung
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

6.  Maturation of dendritic cells by recombinant human CD40L-trimer leads to a homogeneous cell population with enhanced surface marker expression and increased cytokine production.

Authors:  P A Würtzen; M H Nissen; M H Claesson
Journal:  Scand J Immunol       Date:  2001-06       Impact factor: 3.487

7.  Administration of endotoxin associated with lipopolysaccharide tolerance protects mice against fungal infection.

Authors:  N Rayhane; C Fitting; O Lortholary; F Dromer; J M Cavaillon
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

8.  Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock.

Authors:  T Sfeir; D C Saha; M Astiz; E C Rackow
Journal:  Crit Care Med       Date:  2001-01       Impact factor: 7.598

9.  Protection of mice from group A streptococcal skin infection by interleukin-12.

Authors:  D W Metzger; R Raeder; V H Van Cleave; M D Boyle
Journal:  J Infect Dis       Date:  1995-06       Impact factor: 5.226

10.  Immunoparalysis as a cause for invasive aspergillosis?

Authors:  Koen J Hartemink; Marinus A Paul; Jan Jaap Spijkstra; Armand R J Girbes; Kees H Polderman
Journal:  Intensive Care Med       Date:  2003-05-24       Impact factor: 17.440

View more
  23 in total

Review 1.  Advances in the management of sepsis and the understanding of key immunologic defects.

Authors:  Lee P Skrupky; Paul W Kerby; Richard S Hotchkiss
Journal:  Anesthesiology       Date:  2011-12       Impact factor: 7.892

2.  Dose-dependent effect of anti-CTLA-4 on survival in sepsis.

Authors:  Shigeaki Inoue; Lulong Bo; Jinjun Bian; Jacqueline Unsinger; Katherine Chang; Richard S Hotchkiss
Journal:  Shock       Date:  2011-07       Impact factor: 3.454

3.  CD40-CD40 Ligand Pathway is a Major Component of Acute Neuroinflammation and Contributes to Long-term Cognitive Dysfunction after Sepsis.

Authors:  Monique Michels; Lucinéia Gainski Danieslki; Andriele Vieira; Drielly Florentino; Dhébora Dall'Igna; Letícia Galant; Beatriz Sonai; Francieli Vuolo; Franciele Mina; Bruna Pescador; Diogo Dominguini; Tatiana Barichello; João Quevedo; Felipe Dal-Pizzol; Fabrícia Petronilho
Journal:  Mol Med       Date:  2015-03-26       Impact factor: 6.354

4.  Immunosuppression in patients who die of sepsis and multiple organ failure.

Authors:  Jonathan S Boomer; Kathleen To; Kathy C Chang; Osamu Takasu; Dale F Osborne; Andrew H Walton; Traci L Bricker; Stephen D Jarman; Daniel Kreisel; Alexander S Krupnick; Anil Srivastava; Paul E Swanson; Jonathan M Green; Richard S Hotchkiss
Journal:  JAMA       Date:  2011-12-21       Impact factor: 56.272

Review 5.  Defects in innate and adaptive immunity in patients with sepsis and health care associated infection.

Authors:  Thomas Ryan; John D Coakley; Ignacio Martin-Loeches
Journal:  Ann Transl Med       Date:  2017-11

6.  Anti-PD-L1 peptide improves survival in sepsis.

Authors:  Yuichiro Shindo; Jacquelyn S McDonough; Katherine C Chang; Murali Ramachandra; Pottayil G Sasikumar; Richard S Hotchkiss
Journal:  J Surg Res       Date:  2016-09-08       Impact factor: 2.192

7.  Effects of simvastatin on the function of splenic CD4+ and CD8+ T cells in sepsis mice.

Authors:  Bingbing Kong; Xiaofeng Wang; Wenping Yang; Xin Zhao; Rong Zhang; Yu Wang
Journal:  Immunol Res       Date:  2018-06       Impact factor: 2.829

Review 8.  Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach.

Authors:  Richard S Hotchkiss; Guillaume Monneret; Didier Payen
Journal:  Lancet Infect Dis       Date:  2013-03       Impact factor: 25.071

9.  Persistent lymphopenia after diagnosis of sepsis predicts mortality.

Authors:  Anne M Drewry; Navdeep Samra; Lee P Skrupky; Brian M Fuller; Stephanie M Compton; Richard S Hotchkiss
Journal:  Shock       Date:  2014-11       Impact factor: 3.454

10.  Proinflammatory modulation of the surface and cytokine phenotype of monocytes in patients with acute Charcot foot.

Authors:  Luigi Uccioli; Anna Sinistro; Cristiana Almerighi; Chiara Ciaprini; Antonella Cavazza; Laura Giurato; Valeria Ruotolo; Francesca Spasaro; Erika Vainieri; Giovanni Rocchi; Alberto Bergamini
Journal:  Diabetes Care       Date:  2009-10-30       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.